INCY:NASDAQ
Incyte Corp
$123.28
arrow_downward
-2.17%(-2.73) 1D
$123.28
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$125.09
High
$126.31
Low
$122.58
Mkt. cap
24.99B
Avg. vol.
1.44M
Volume
25.00
P/E ratio
15.71
52-wk high
$132.58
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
Open
$125.09
High
$126.31
Low
$122.58
Mkt. cap
24.99B
Avg. vol.
1.44M
Volume
25.00
P/E ratio
15.71
52-wk high
$132.58
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
News Corp
·
11 hours ago
Incyte Corp. stock outperforms competitors despite losses on the day
MarketWatch
·
11 hours ago
Incyte Corp. stock outperforms competitors despite losses on the day
Investing.com
·
17 hours ago
Incyte at Cantor conference: pipeline advances, post-Jakafi plan
TradingView
·
18 hours ago
INCY: Late-stage pipeline progress and targeted launches position for strong post-2029 growth
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEOHervé Hoppenot
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com